Company

DIESSE is an Italian company with an integrated and entirely inhouse production of in vitro diagnostic systems. Its headquarters are in Siena. Since its foundation in 1980, the company has developed, produced and marketed innovative diagnostic systems primarily in the field of immunodiagnostics and automatic measurement of erythrocyte sedimentation rate (ESR). The company has a global presence in over 100 countries, three production sites and a research centre where the design and implementation of tests and new automated diagnostic detection tools meet Italian design and cutting-edge technology, making Diesse synonymous with “Diagnostics Evolution”.

Mission

We use our history and our skills in everyday work, integrating advanced research, Made in Italy production and global marketing, for the evolution of our diagnostics systems towards the medicine of future in a sustainable, ethical and transparent way.

Diagnostics Evolution

In the eighties, when we developed the world’s first system for the fully automated measurement of ESR directly in the test tube, we had one word in mind: evolution. The evolution of research, the evolution of safety for lab technicians, the evolution of In Vitro Diagnostics. When it is driven by a continuous will to innovate, high skills and advanced technological development, evolution is unstoppable.Today this evolution leads us towards the medicine of the future.

Research & Development

Research & Development


In-house biomaterial production

In-house biomaterial production


Quality

Quality


Global presence

Global presence


Entirely Made in Italy

Entirely Made in Italy


Quality-control

Quality-control


IVD technology innovation

IVD technology innovation


Powered by Italian Design

Powered by Italian Design


People centered

People centered


Timeline

Quality

DIESSE Diagnostica Senese SpA has been operating for many years in accordance with leading standards for quality management systems, ensuring traceability, transparency, highest quality of its processes, products and services and working on continuous improvement.
The Company is certified in accordance with UNI EN ISO 9001: 2015 and EN ISO 13485: 2016, also in compliance with the MDSAP (Medical Device Single Audit Program) program.
As part of this program, DIESSE Diagnostica Senese SpA has obtained, starting from 2019, the MDSAP certification in accordance with the Regulations of all 5 countries participating to the program: the United States, Canada, Australia, Japan and Brazil.
All products are CE marked in accordance with the European Directive 98/79/EC concerning In Vitro Diagnostic Medical Devices and the relative applicable harmonized standards.

Corporate Social Responsibility

DIESSE Diagnostica Senese S.p.A. (DIESSE) is committed to conducting, executing, and monitoring its activities in an ethical, socially responsible and transparent way to safeguard the respect and preservation of the environment, as well as cultural and social heritage, in order to protect this generation and those to come.

The principles that DIESSE intends to follow are described in the Corporate Social Responsibility policy and are in agreement with its Code of Ethics and its Organization, Management and Control Model (in compliance with the Italian Legislative Decree n. 231/2001, Italian law on crime-risk prevention within business activities).

Transparency

Diesse, has decided to improve the relations with the healthcare professionals with whom it cooperates and has therefore modified its Code of Ethics.

The improvement consists of TRANSPARENCY: publication of money transfers, introduced in order to guarantee integrity in relation with medical-health operators and stakeholders.

Starting from 1st January 2021, with reference to the data related to the year 2020, Diesse will publish, on annual basis, the money transfers directly or indirectly to Healthcare Professionals, Healthcare Organizations and Third Parties, within the first six months of the next year.

The data will be published on the company website, in compliance with the regulation on the protection of personal data and will be available for a period of at least three years from the date of publication.
Diesse is thus preparing to guarantee the "right to know" of its own relationships of economic importance with professionals in the health sector and health organizations, also in compliance with the principles and behaviors of the Code of Ethics of Confindustria Medical Devices.